.svg)
Access to Psychedelics for All Canadians
Become a Friend of the PACWhy we exist
To awaken a revolution of wellbeing
Our Mission
To educate about and advocate for access to all psychedelics as a basic human right
Our Vision
People living in harmony with each other and nature
Our Values
Love, Courage, Communication,
Integrity, Impact, Sustainability
"That psychedelics have been time tested for thousands of years, and being revered across cultures and continents, speaks to their deep history of beneficial influence. Modern science is now validating what our ancestors knew: psychedelics are essential for mental and spiritual well being."
- Paul Stamets
"Psychedelic plants, fungi and compounds are tools for learning; they place in our hands the keys to learn how to become better humans."
- Dennis McKenna
Why join the PAC Business Alliance?
The PAC Business Alliance serves the business in Canada’s psychedelic space. Think of it as the psychedelic chamber of commerce. Contribute to the PAC advocacy regarding legalization of medical psychedelics. Participate in business-focused webinars, networking events, roundtables and research incubators. Network and communicate with the PAC nationwide psychedelic community.
Join the Business AllianceEvents & Webinars
If you haven't signed up for a membership with us, now is the time. When you sign up for our membership or to one of our webinars, you are directly supporting our mission to educate about and advocate for psychedelic medicines.
Furthermore, your membership fees help us directly fund our advocacy campaign "Canada Supports" plus you get the benefit of connecting with others within our community and access to our networking events and webinars.
Sign up for our membership and get access to all the events below!
Past
Upcoming
Webinar
January 26, 2023
at 4 PM PST / 7 PM EST on Zoom
The State of Psychedelic Law 2023
2022 was a monumental year for positive action on Psychedelics in Canada.
Find out what Canada has done to become one of the leading nations in the world for (still too slowly for many) opening itself to accessible psychedelics.
Listen to top Psychedelics lawyers from across Canada discuss Marc Goldrub's newly released report: 2023, The State of Psychedelic Law.
Past
Upcoming
Webinar
January 19, 2023
at 4 PM PST / 7 PM EST on Zoom
Alberta's New Psychedelic Therapy Regulations
Alberta has just become the first province to publish a regulation on psychedelics use in a therapeutic setting. Does their acknowledgment of the inevitability of psychedelic therapy as a healthcare modality outweigh the criticisms the new requirements have received from many within Alberta's psychedelic community?
Join leaders from the Psychedelics community in Alberta as they examine the much-discussed new Alberta regulations on psychedelic therapy, taking effect in January, 2023.
.png)
Past
Upcoming
Webinar
November 24, 2022
at 4 PM PST / 7 PM EST on Zoom
Courtroom Drama: Therapsil - Taking the Government to Court to get Psychedelic Access for Patients
In a case reminiscent of David and Goliath, Therapsil, represented by lawyer Paul Lewin, is going to the Supreme Court on behalf of their clients to ensure vital access to psychedelic medicine for end of life patients.
Noted Canadian lawyer Paul Lewin has won many cases challenging drug laws in courts across Canada. His latest action is suing the government of Canada on behalf of Therapsil and its clients, to give end-of-life patients access to psilocybin without having to access this medicine through the many layered red tape of the Canadian government.
Also joining in this important conversation is Therapsil's Spencer Hawkswell and Human Rights Lawyer John Conroy (who also has many victories at the Supreme Court of Canada). Together they will update us on the progress of the groundbreaking case to get access to psilocybin for all Canadians.
Join us to show your solidarity with making psychedelic medicine a legal right for all in Canada!
Canada Supports Campaign
The PAC to introduce new regulatory change to Health Canada
Canada overwhelmingly supports access to new regulations with polling numbers showcasing the need for change including, 78% of Canadians polled support or somewhat support a government that legalized psilocybin-assisted psychotherapy to improve the quality of life for terminally ill patients.
The Psychedelic Association of Canada and other experts from across Canada have been meeting with Members of Parliament, senior government officials, representatives from all parties, and national stakeholders over the past 10 months and encountered unanimous support for access to psilocybin therapy with a palliative diagnosis.
With public support at an all-time high, we are focusing on introducing evidence-informed regulations to officials at Health Canada. We come together with a group of key experts including palliative care professionals, therapists, MDs, non-profit supports, industry, medical and legal experts to communicate, petition, and deliver a regulatory framework that will transform the lives of Canadians who deserve access to medicine that can help them overcome their most debilitating mental anxieties.
Work with us, lend your support and help us create a new path for legal psilocybin-assisted therapy in Canada. #canadasupports
#psychedelicassociation
15,000 signatures!
Decriminalize healing plant medicines and fungi in Canada
Our petition's first go is now over! We gathered close to 15,000 signatures and the petition has been read in the House of Commons this fall. Thank you for your support!
Stay tuned for a NEW petition as we won't stop this campaign until our voices have been heard in Ottawa and across Canada.
Thank you to Chris Bennett, Paul Manly, Kirk Tousaw, Rob Laurie, Jovian Francey, Trevor Millar, and others who started this petition process!
Get more information on psychedelics and the community
Curious about psychedelics and their potential for therapeutic and health benefits? Want to get plugged into the movement locally? Visit our Resources centre for books we recommend, films to watch, a global ecosystem map, training programs, and ongoing clinical trials.
Visit our resources centre